menu
    • menu

    Company profile for Edwards Lifesciences Corporation

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. Driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that enable them to save and enhance lives.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Edwards Lifesciences CorporationUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    One Edwards Way Irvine, CA 92614
    Telephone
    Telephone
    949-250-2500
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.edwards.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/edwards-lifesciences
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/edwardslifesci

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FTC wins blocking Edwards Lifesciences' acquisition of JenaValve
    FTC wins blocking Edwards Lifesciences' acquisition of JenaValve

    09 Jan 2026

    // REUTERS

    https://www.reuters.com/world/ftc-wins-ruling-blocking-edwards-lifesciences-acquisition-jenavalve-2026-01-09/

    REUTERS
    09 Jan 2026
    Share Share
    Edwards Nets FDA Approval For Sapien M3 Mitral Valve Replacement
    Edwards Nets FDA Approval For Sapien M3 Mitral Valve Replacement

    23 Dec 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/medtech/edwards-claims-fda-approval-sapien-m3-transcatheter-mitral-valve-replacement

    FIERCE BIOTECH
    23 Dec 2025
    Share Share
    Edwards Lifesciences Beats Q3 on Strong Heart Device Sales
    Edwards Lifesciences Beats Q3 on Strong Heart Device Sales

    31 Oct 2025

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/edwards-lifesciences-beats-quarterly-estimates-strength-heart-devices-2025-10-30/

    REUTERS
    31 Oct 2025
    Share Share
    Edwards Lifesciences Introduces Next-Gen Heart Valve in India
    Edwards Lifesciences Introduces Next-Gen Heart Valve in India

    05 Sep 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/edwards-lifesciences-launches-next-gen-transcatheter-heart-valve-in-india-17731

    INDPHARMAPOST
    05 Sep 2025
    Share Share
    Edwards Lifesciences Replies to FTC Block on JenaValve Deal
    Edwards Lifesciences Replies to FTC Block on JenaValve Deal

    06 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250806182521/en/Edwards-Lifesciences-Comments-on-FTCs-Action-to-Block-Proposed-Acquisition-of-JenaValve

    BUSINESSWIRE
    06 Aug 2025
    Share Share
    Edwards TAVR FDA Approved for Asymptomatic Severe Aortic Stenosis
    Edwards TAVR FDA Approved for Asymptomatic Severe Aortic Stenosis

    01 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250501280519/en/Edwards-TAVR-Receives-FDA-Approval-for-Patients-With-Asymptomatic-Severe-Aortic-Stenosis

    BUSINESSWIRE
    01 May 2025
    Share Share

    ABOUT THIS PAGE

    Contact Edwards Lifesciences Corporation and get a quotation

    Edwards Lifesciences Corporation is a supplier offers 1 products (APIs, Excipients or Intermediates).

    Find a price of Bovine Serum bulk with CEP offered by Edwards Lifesciences Corporation

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search